Arkolith/Insider Trading/ADPT/Form 4

Rubinstein Julie

President and COOAdaptive Biotechnologies Corp (ADPT) · full profile →Form 4 · filed Apr 8, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$991K
Net Open-Market Flow
-$991K
Transactions
12
8 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 8, 2026Sell(S)31K$14.83$457K434K
Apr 8, 2026Sell(S)100$15.48$2K434K
Apr 8, 2026Option exercise(M)15K$7.27$107K453K
Apr 8, 2026Option exercise(M)12K$12.14$144K465K
Apr 7, 2026Option exercise(M)15K$7.27$107K458K
Apr 7, 2026Sell(S)19K$13.56$258K439K
Apr 6, 2026Option exercise(M)15K$7.27$107K462K
Apr 6, 2026Sell(S)19K$14.33$273K443K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 8, 2026Option exercise(M)15K—$038K
Apr 8, 2026Option exercise(M)12K—$0392K
Apr 7, 2026Option exercise(M)15K—$052K
Apr 6, 2026Option exercise(M)15K—$067K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001780664-26-000022) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML